APA

Schats K. A., Van Vré E. A., De Schepper S., Boeckx C., Schrijvers D. M., Waelput W., Fransen E., Vanden Bempt I., Neyns B., De Meester I. & Kockx M. M. (20170623). Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system. : Histopathology.

Chicago

Schats Kelly A, Van Vré Emily A, De Schepper Stefanie, Boeckx Carolien, Schrijvers Dorien M, Waelput Wim, Fransen Erik, Vanden Bempt Isabelle, Neyns Bart, De Meester Ingrid and Kockx Mark M. 20170623. Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system. : Histopathology.

Harvard

Schats K. A., Van Vré E. A., De Schepper S., Boeckx C., Schrijvers D. M., Waelput W., Fransen E., Vanden Bempt I., Neyns B., De Meester I. and Kockx M. M. (20170623). Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system. : Histopathology.

MLA

Schats Kelly A, Van Vré Emily A, De Schepper Stefanie, Boeckx Carolien, Schrijvers Dorien M, Waelput Wim, Fransen Erik, Vanden Bempt Isabelle, Neyns Bart, De Meester Ingrid and Kockx Mark M. Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system. : Histopathology. 20170623.